Kairos Pharma (KAPA) Operating Expenses (2023 - 2025)
Kairos Pharma's (KAPA) quarterly Operating Expenses came in at $1.5 million in Q2 2025, up 555.86% YoY from $222000.0 in Q2 2024, and up 15.01% on a QoQ basis from $1.3 million in Q1 2025.
Kairos Pharma (KAPA) Operating Expenses (2023 - 2025) Analysis & Trends
Kairos Pharma (KAPA) has 3 years of Operating Expenses data on file, last reported at $1.5 million in Q2 2025.
- Quarterly Operating Expenses rose 555.86% year-over-year to $1.5 million in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $4.2 million (up 78.27% YoY) and the FY2025 annual result came in at $5.6 million, up 137.81% from the prior year.
- Operating Expenses climbed to $1.5 million in Q2 2025, from $1.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $1.5 million in Q2 2025 to a low of $222000.0 in Q2 2024.
- A 3-year average of $804500.0 and a median of $736000.0 in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2024 — Operating Expenses soared 32.78% — and 2025, when it surged 555.86%.
- Tracing KAPA's Operating Expenses over 3 years: stood at $1.1 million in 2023, then surged by 32.78% to $1.4 million in 2024, then rose by 0.69% to $1.5 million in 2025.
- The last three Operating Expenses figures came in at $1.5 million (Q2 2025), $1.3 million (Q1 2025), and $1.4 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Kairos Pharma | 5.50 Mn | 168,380.07 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.27 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 383,000.00 |
| Jun 30, 2024 | 222,000.00 |
| Mar 31, 2024 | 287,000.00 |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 287,000.00 |